180 related articles for article (PubMed ID: 12086901)
1. Staging of pancreatic cancer before and after neoadjuvant chemoradiation.
White RR; Paulson EK; Freed KS; Keogan MT; Hurwitz HI; Lee C; Morse MA; Gottfried MR; Baillie J; Branch MS; Jowell PS; McGrath KM; Clary BM; Pappas TN; Tyler DS
J Gastrointest Surg; 2001; 5(6):626-33. PubMed ID: 12086901
[TBL] [Abstract][Full Text] [Related]
2. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
[TBL] [Abstract][Full Text] [Related]
3. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?
Kim HJ; Czischke K; Brennan MF; Conlon KC
J Gastrointest Surg; 2002; 6(5):763-9. PubMed ID: 12399067
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.
White RR; Hurwitz HI; Morse MA; Lee C; Anscher MS; Paulson EK; Gottfried MR; Baillie J; Branch MS; Jowell PS; McGrath KM; Clary BM; Pappas TN; Tyler DS
Ann Surg Oncol; 2001 Dec; 8(10):758-65. PubMed ID: 11776488
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?
Chen KT; Devarajan K; Milestone BN; Cooper HS; Denlinger C; Cohen SJ; Meyer JE; Hoffman JP
Ann Surg Oncol; 2014 Feb; 21(2):662-9. PubMed ID: 24276638
[TBL] [Abstract][Full Text] [Related]
6. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
[TBL] [Abstract][Full Text] [Related]
7. Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study.
Davids JS; Alavi K; Andres Cervera-Servin J; Choi CS; Sturrock PR; Sweeney WB; Maykel JA
Int J Surg; 2014 Dec; 12(12):1295-9. PubMed ID: 25448648
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
[TBL] [Abstract][Full Text] [Related]
9. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
[TBL] [Abstract][Full Text] [Related]
10. Complete pathological response following down-staging chemoradiation in locally advanced pancreatic cancer: challenging the boundaries.
Khan AZ; Pitsinis V; Mudan SS
World J Gastroenterol; 2007 Dec; 13(47):6433-5. PubMed ID: 18081235
[TBL] [Abstract][Full Text] [Related]
11. Impact of laparoscopic staging in the treatment of pancreatic cancer.
Jimenez RE; Warshaw AL; Rattner DW; Willett CG; McGrath D; Fernandez-del Castillo C
Arch Surg; 2000 Apr; 135(4):409-14; discussion 414-5. PubMed ID: 10768705
[TBL] [Abstract][Full Text] [Related]
12. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
13. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
Evans DB; Varadhachary GR; Crane CH; Sun CC; Lee JE; Pisters PW; Vauthey JN; Wang H; Cleary KR; Staerkel GA; Charnsangavej C; Lano EA; Ho L; Lenzi R; Abbruzzese JL; Wolff RA
J Clin Oncol; 2008 Jul; 26(21):3496-502. PubMed ID: 18640930
[TBL] [Abstract][Full Text] [Related]
14. Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation.
Wayne JD; Abdalla EK; Wolff RA; Crane CH; Pisters PW; Evans DB
Oncologist; 2002; 7(1):34-45. PubMed ID: 11854545
[TBL] [Abstract][Full Text] [Related]
15. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation.
Katz MH; Varadhachary GR; Fleming JB; Wolff RA; Lee JE; Pisters PW; Vauthey JN; Abdalla EK; Sun CC; Wang H; Crane CH; Lee JH; Tamm EP; Abbruzzese JL; Evans DB
Ann Surg Oncol; 2010 Jul; 17(7):1794-801. PubMed ID: 20162463
[TBL] [Abstract][Full Text] [Related]
16. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiation in resectable pancreatic cancer.
Chandler NM; Canete JJ; Stuart KE; Callery MP
J Hepatobiliary Pancreat Surg; 2003; 10(1):61-6. PubMed ID: 12918459
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
Mehta VK; Fisher G; Ford JA; Poen JC; Vierra MA; Oberhelman H; Niederhuber J; Bastidas JA
J Gastrointest Surg; 2001; 5(1):27-35. PubMed ID: 11309645
[TBL] [Abstract][Full Text] [Related]
19. Preoperative prediction of complete resection in pancreatic cancer.
Shah D; Fisher WE; Hodges SE; Wu MF; Hilsenbeck SG; Charles Brunicardi F
J Surg Res; 2008 Jun; 147(2):216-20. PubMed ID: 18498873
[TBL] [Abstract][Full Text] [Related]
20. [Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection].
Delpero JR; Turrini O
Cancer Radiother; 2006 Nov; 10(6-7):462-70. PubMed ID: 16987678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
